This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Slayter, M. V. Articles by Sporn, M. B. Search for Related Content PubMed PubMed Citation Articles by Slayter, M. V. Articles by Sporn, M. B.

Histogenesis of Induced Prostate and Seminal Vesicle Carcinoma in Lobund-Wistar Rats: A System for Histological Scoring and Grading

Department of Veterinary Pathology, Armed Forces Institute of Pathology, Washington, DC 20306 [M. V. S.], and Laboratory of Chemoprevention, National Cancer Institute, NIH, Bethesda, Maryland 20892 [M. A. A., K. K., J. M. S., M. B. S.]

We have developed a grading system for the evaluation of the histogenesis of neoplastic lesions of the prostate and seminal vesicle of the laboratory rat. Prostatic and seminal vesicle carcinomas were induced in Lobund-Wistar rats by initiation with 30 mg/kg N-nitroso-N-methylurea i.v., followed by promotion with 40 mg testosterone propionate implants 1 week later and at 3-month intervals thereafter. Experimental and control groups were sacrificed at various time points between 5 and 11 months after dosing with N-nitroso-N-methylurea in order to visualize progressive stages of carcinogenesis of the dorsolateral prostate, the anterior prostate, and the seminal vesicle. A system of staging was created which allows three different categories (in situ change, invasion, desmoplasia) of tumor development to be ranked progressively in a manner conducive to nonparametric analysis. Each category was then further subdivided to create a total of six stages. This system can be used to evaluate agents which modify tumor induction or suppression. The application of this staging system to the measurement of the effects of the synthetic retinoid, 4-hydroxyphenyl retinamide, on prostatic carcinogenesis in the Lobund-Wistar rat is described.

¹ Co-senior authors of this article.

Received 10/11/93. Accepted 1/11/94.

This article has been cited by other articles:

				M. Pollard and M. A. Suckow Hormone-Refractory Prostate Cancer in the Lobund-Wistar Rat Experimental Biology and Medicine, September 1, 2005; 230(8): 520 - 526. [Abstract] [Full Text] [PDF]

				A. Hikosaka, M. Asamoto, N. Hokaiwado, K. Kato, K. Kuzutani, K. Kohri, and T. Shirai Inhibitory effects of soy isoflavones on rat prostate carcinogenesis induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) Carcinogenesis, March 1, 2004; 25(3): 381 - 387. [Abstract] [Full Text] [PDF]

				K. Song, S. C. Cornelius, and D. Danielpour Development and Characterization of DP-153, a Nontumorigenic Prostatic Cell Line That Undergoes Malignant Transformation by Expression of Dominant-negative Transforming Growth Factor {beta} Receptor Type II Cancer Res., August 1, 2003; 63(15): 4358 - 4367. [Abstract] [Full Text] [PDF]

				K. T. Christov, R. C. Moon, D. D. Lantvit, C. W. Boone, V. E. Steele, R. A. Lubet, G. J. Kelloff, and J. M. Pezzuto 9-cis-Retinoic Acid but Not 4-(Hydroxyphenyl)retinamide Inhibits Prostate Intraepithelial Neoplasia in Noble Rats Cancer Res., September 15, 2002; 62(18): 5178 - 5182. [Abstract] [Full Text] [PDF]